Literature DB >> 30902786

MicroRNA 4651 regulates nonsense-mediated mRNA decay by targeting SMG9 mRNA.

Yanjie Tan1, Zhenfa Ma1, Yi Jin1, Ruojun Zong1, Jian Wu2, Zhuqing Ren3.   

Abstract

Nonsense-mediated mRNA decay (NMD) is originally identified as a conserved RNA surveillance mechanism that rapidly degrades aberrant mRNA containing premature termination codons (PTCs). However, the molecular regulation mechanisms by which microRNAs inhibit NMD has not been well understood. Here we identified that miR-4651 participated in the NMD pathway by downregulating expression levels of SMG9. We provided evidences that (1) Overexpression of miR-4651 mimic significantly inhibited the expression of SMG9 (P < 0.05); (2) NMD substrates genes, TBL2 and GADD45B were both increased at mRNA and protein expression levels when SMG9 was suppressed by siRNA, whereas decreased by SMG9 overexpression; (3) Expression of SMG9 was significantly increased but TBL2, GADD45B were significantly decreased when cells transfected with miR-4651 inhibitor (P < 0.05). These results indicated that miR-4651 regulated NMD by targeting SMG9 mRNA. Our study highlights that miR-4651 represses NMD. miR-4651 targets SMG9 and represses the expression levels of SMG9. NMD activity is decreased additionally when SMG9 is inhibited. The present study provides evidence for microRNA/NMD regulatory mechanism.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  NMD; SMG9; miR-4651

Mesh:

Substances:

Year:  2019        PMID: 30902786     DOI: 10.1016/j.gene.2019.03.031

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  2 in total

1.  MicroRNA-4651 represses hepatocellular carcinoma cell growth and facilitates apoptosis via targeting FOXP4.

Authors:  Yun Li; Xiaoying Wang; Zhonggang Li; Bingxia Liu; Chaoyu Wu
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

2.  miR-4651 inhibits cell proliferation of gingival mesenchymal stem cells by inhibiting HMGA2 under nifedipine treatment.

Authors:  Xiao Han; Ruzhuang Yang; Haoqing Yang; Yangyang Cao; Nannan Han; Chen Zhang; Ruitang Shi; Zhengting Zhang; Zhipeng Fan
Journal:  Int J Oral Sci       Date:  2020-03-31       Impact factor: 6.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.